Stopped: Difficulty in patient recruitment
Evaluate the INFUSE/MASTERGRAFTâ„¢ Delayed Healing Device as an alternative/replacement to autograft in the treatment of tibial delayed healing.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Overall Success
Timeframe: 12 Months